MMRC Scientific Agenda Priority Research Areas

The MMRF and MMRC identified three priority research areas that are critical in bringing new therapies to patients and in advancing our understanding of the disease.

• Genomics, with research efforts focused on the identification and validation of new druggable targets for myeloma
• Compound and Target Validation and Prioritization, with research efforts focused on the validation of existing compounds and moving these onward into early-stage clinical trials
• Clinical Trials and Correlative Sciences, with research efforts focused on the design and implementation of early-stage clinical trials to advance promising treatments into the clinic where patients can benefit

All of these research programs are now underway.